Corona / Covid-19
Developed and validated in cooperation with LIONEX, a German research orientated diagnostic company, we are pleased to introduce highly specific and accurate Immunoassays and rapid tests for serological SARS-COV2 (COVID-19) testing
The biggest advantage of immunoassays and rapid tests is their ability to detect past infections, or those that have recovered and have developed antibodies against the virus. Broad based testing for IgG SARS-CoV2 can help epidemiological studies about the spread of the virus to include possible herd immunity.